frequent somatic mutations gnaq uveal melanoma blue naevi
braf nras common targets somatic mutations benign malignant neoplasms arise melanocytes situated epithelial structures lead constitutive activation mitogen activated protein map kinase pathway however braf nras mutations absent number melanocytic neoplasms equivalent oncogenic events currently unknown report frequent somatic mutations heterotrimeric g protein alpha-subunit gnaq blue naevi % ocular melanoma uvea % mutations occur exclusively codon ras like domain result constitutive activation turning gnaq dominant acting oncogene results demonstrate alternative route map kinase activation melanocytic neoplasia providing new opportunities therapeutic intervention
